img

Global Motion Sickness Pills Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Motion Sickness Pills Market Research Report 2024

Motion sickness is a common problem in people traveling by car, train, airplanes, and especially boats. Motion sickness is a condition experienced by patient caused due to difference between the visually perceived motion and vestibular system’s senses of movement. Motion sickness is characterized by a set of symptoms such as nausea, fatigue, and dizziness.
According to Mr Accuracy reports’s new survey, global Motion Sickness Pills market is projected to reach US$ 1055.7 million in 2034, increasing from US$ 854 million in 2024, with the CAGR of 3.1% during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Motion Sickness Pills market research.
The motion sickness pills market is driven by several factors. One of the primary drivers is the increasing prevalence of motion sickness among individuals traveling by various modes of transportation, such as cars, planes, trains, and boats. Motion sickness, characterized by symptoms like nausea, dizziness, and vomiting, affects a significant portion of the population, leading to a rising demand for effective treatment options. Additionally, the growing tourism and travel industry, coupled with the increasing popularity of adventure and recreational activities, have expanded the potential consumer base for motion sickness pills. The convenience and ease of use offered by these pills, providing quick relief from symptoms, further contribute to their market growth. Moreover, advancements in drug formulations, such as non-drowsy and long-lasting options, have improved patient compliance and satisfaction. Additionally, the availability of over-the-counter options and increased accessibility of these medications in pharmacies and online platforms have further fueled the demand for motion sickness pills. Overall, the motion sickness pills market is driven by the increasing prevalence of motion sickness, expanding travel industry, advancements in drug formulations, and improved accessibility to these medications.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Motion Sickness Pills market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


GlaxoSmithKline
Prestige Brands
WellSpring Pharmaceutical Corporation
Baxter International
Vartaris
Novartis
Pfizer
Myungmoon Pharm
Caleb Pharmaceuticals
Segment by Type
Anticholinergic
Antihistamines
Others

Segment by Application


Adults
Children
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Motion Sickness Pills report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Motion Sickness Pills Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Anticholinergic
1.2.3 Antihistamines
1.2.4 Others
1.3 Market by Application
1.3.1 Global Motion Sickness Pills Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Adults
1.3.3 Children
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Motion Sickness Pills Market Perspective (2018-2034)
2.2 Motion Sickness Pills Growth Trends by Region
2.2.1 Global Motion Sickness Pills Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Motion Sickness Pills Historic Market Size by Region (2018-2023)
2.2.3 Motion Sickness Pills Forecasted Market Size by Region (2024-2034)
2.3 Motion Sickness Pills Market Dynamics
2.3.1 Motion Sickness Pills Industry Trends
2.3.2 Motion Sickness Pills Market Drivers
2.3.3 Motion Sickness Pills Market Challenges
2.3.4 Motion Sickness Pills Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Motion Sickness Pills Players by Revenue
3.1.1 Global Top Motion Sickness Pills Players by Revenue (2018-2023)
3.1.2 Global Motion Sickness Pills Revenue Market Share by Players (2018-2023)
3.2 Global Motion Sickness Pills Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Motion Sickness Pills Revenue
3.4 Global Motion Sickness Pills Market Concentration Ratio
3.4.1 Global Motion Sickness Pills Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Motion Sickness Pills Revenue in 2024
3.5 Motion Sickness Pills Key Players Head office and Area Served
3.6 Key Players Motion Sickness Pills Product Solution and Service
3.7 Date of Enter into Motion Sickness Pills Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Motion Sickness Pills Breakdown Data by Type
4.1 Global Motion Sickness Pills Historic Market Size by Type (2018-2023)
4.2 Global Motion Sickness Pills Forecasted Market Size by Type (2024-2034)
5 Motion Sickness Pills Breakdown Data by Application
5.1 Global Motion Sickness Pills Historic Market Size by Application (2018-2023)
5.2 Global Motion Sickness Pills Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Motion Sickness Pills Market Size (2018-2034)
6.2 North America Motion Sickness Pills Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Motion Sickness Pills Market Size by Country (2018-2023)
6.4 North America Motion Sickness Pills Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Motion Sickness Pills Market Size (2018-2034)
7.2 Europe Motion Sickness Pills Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Motion Sickness Pills Market Size by Country (2018-2023)
7.4 Europe Motion Sickness Pills Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Motion Sickness Pills Market Size (2018-2034)
8.2 Asia-Pacific Motion Sickness Pills Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Motion Sickness Pills Market Size by Region (2018-2023)
8.4 Asia-Pacific Motion Sickness Pills Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Motion Sickness Pills Market Size (2018-2034)
9.2 Latin America Motion Sickness Pills Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Motion Sickness Pills Market Size by Country (2018-2023)
9.4 Latin America Motion Sickness Pills Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Motion Sickness Pills Market Size (2018-2034)
10.2 Middle East & Africa Motion Sickness Pills Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Motion Sickness Pills Market Size by Country (2018-2023)
10.4 Middle East & Africa Motion Sickness Pills Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Detail
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Motion Sickness Pills Introduction
11.1.4 GlaxoSmithKline Revenue in Motion Sickness Pills Business (2018-2023)
11.1.5 GlaxoSmithKline Recent Development
11.2 Prestige Brands
11.2.1 Prestige Brands Company Detail
11.2.2 Prestige Brands Business Overview
11.2.3 Prestige Brands Motion Sickness Pills Introduction
11.2.4 Prestige Brands Revenue in Motion Sickness Pills Business (2018-2023)
11.2.5 Prestige Brands Recent Development
11.3 WellSpring Pharmaceutical Corporation
11.3.1 WellSpring Pharmaceutical Corporation Company Detail
11.3.2 WellSpring Pharmaceutical Corporation Business Overview
11.3.3 WellSpring Pharmaceutical Corporation Motion Sickness Pills Introduction
11.3.4 WellSpring Pharmaceutical Corporation Revenue in Motion Sickness Pills Business (2018-2023)
11.3.5 WellSpring Pharmaceutical Corporation Recent Development
11.4 Baxter International
11.4.1 Baxter International Company Detail
11.4.2 Baxter International Business Overview
11.4.3 Baxter International Motion Sickness Pills Introduction
11.4.4 Baxter International Revenue in Motion Sickness Pills Business (2018-2023)
11.4.5 Baxter International Recent Development
11.5 Vartaris
11.5.1 Vartaris Company Detail
11.5.2 Vartaris Business Overview
11.5.3 Vartaris Motion Sickness Pills Introduction
11.5.4 Vartaris Revenue in Motion Sickness Pills Business (2018-2023)
11.5.5 Vartaris Recent Development
11.6 Novartis
11.6.1 Novartis Company Detail
11.6.2 Novartis Business Overview
11.6.3 Novartis Motion Sickness Pills Introduction
11.6.4 Novartis Revenue in Motion Sickness Pills Business (2018-2023)
11.6.5 Novartis Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Detail
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Motion Sickness Pills Introduction
11.7.4 Pfizer Revenue in Motion Sickness Pills Business (2018-2023)
11.7.5 Pfizer Recent Development
11.8 Myungmoon Pharm
11.8.1 Myungmoon Pharm Company Detail
11.8.2 Myungmoon Pharm Business Overview
11.8.3 Myungmoon Pharm Motion Sickness Pills Introduction
11.8.4 Myungmoon Pharm Revenue in Motion Sickness Pills Business (2018-2023)
11.8.5 Myungmoon Pharm Recent Development
11.9 Caleb Pharmaceuticals
11.9.1 Caleb Pharmaceuticals Company Detail
11.9.2 Caleb Pharmaceuticals Business Overview
11.9.3 Caleb Pharmaceuticals Motion Sickness Pills Introduction
11.9.4 Caleb Pharmaceuticals Revenue in Motion Sickness Pills Business (2018-2023)
11.9.5 Caleb Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Motion Sickness Pills Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of Anticholinergic
Table 3. Key Players of Antihistamines
Table 4. Key Players of Others
Table 5. Global Motion Sickness Pills Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 6. Global Motion Sickness Pills Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 7. Global Motion Sickness Pills Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Motion Sickness Pills Market Share by Region (2018-2023)
Table 9. Global Motion Sickness Pills Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 10. Global Motion Sickness Pills Market Share by Region (2024-2034)
Table 11. Motion Sickness Pills Market Trends
Table 12. Motion Sickness Pills Market Drivers
Table 13. Motion Sickness Pills Market Challenges
Table 14. Motion Sickness Pills Market Restraints
Table 15. Global Motion Sickness Pills Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Motion Sickness Pills Market Share by Players (2018-2023)
Table 17. Global Top Motion Sickness Pills Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Motion Sickness Pills as of 2024)
Table 18. Ranking of Global Top Motion Sickness Pills Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Motion Sickness Pills Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Motion Sickness Pills Product Solution and Service
Table 22. Date of Enter into Motion Sickness Pills Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Motion Sickness Pills Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Motion Sickness Pills Revenue Market Share by Type (2018-2023)
Table 26. Global Motion Sickness Pills Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 27. Global Motion Sickness Pills Revenue Market Share by Type (2024-2034)
Table 28. Global Motion Sickness Pills Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Motion Sickness Pills Revenue Market Share by Application (2018-2023)
Table 30. Global Motion Sickness Pills Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 31. Global Motion Sickness Pills Revenue Market Share by Application (2024-2034)
Table 32. North America Motion Sickness Pills Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 33. North America Motion Sickness Pills Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Motion Sickness Pills Market Size by Country (2024-2034) & (US$ Million)
Table 35. Europe Motion Sickness Pills Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 36. Europe Motion Sickness Pills Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Motion Sickness Pills Market Size by Country (2024-2034) & (US$ Million)
Table 38. Asia-Pacific Motion Sickness Pills Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 39. Asia-Pacific Motion Sickness Pills Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Motion Sickness Pills Market Size by Region (2024-2034) & (US$ Million)
Table 41. Latin America Motion Sickness Pills Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 42. Latin America Motion Sickness Pills Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Motion Sickness Pills Market Size by Country (2024-2034) & (US$ Million)
Table 44. Middle East & Africa Motion Sickness Pills Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 45. Middle East & Africa Motion Sickness Pills Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Motion Sickness Pills Market Size by Country (2024-2034) & (US$ Million)
Table 47. GlaxoSmithKline Company Detail
Table 48. GlaxoSmithKline Business Overview
Table 49. GlaxoSmithKline Motion Sickness Pills Product
Table 50. GlaxoSmithKline Revenue in Motion Sickness Pills Business (2018-2023) & (US$ Million)
Table 51. GlaxoSmithKline Recent Development
Table 52. Prestige Brands Company Detail
Table 53. Prestige Brands Business Overview
Table 54. Prestige Brands Motion Sickness Pills Product
Table 55. Prestige Brands Revenue in Motion Sickness Pills Business (2018-2023) & (US$ Million)
Table 56. Prestige Brands Recent Development
Table 57. WellSpring Pharmaceutical Corporation Company Detail
Table 58. WellSpring Pharmaceutical Corporation Business Overview
Table 59. WellSpring Pharmaceutical Corporation Motion Sickness Pills Product
Table 60. WellSpring Pharmaceutical Corporation Revenue in Motion Sickness Pills Business (2018-2023) & (US$ Million)
Table 61. WellSpring Pharmaceutical Corporation Recent Development
Table 62. Baxter International Company Detail
Table 63. Baxter International Business Overview
Table 64. Baxter International Motion Sickness Pills Product
Table 65. Baxter International Revenue in Motion Sickness Pills Business (2018-2023) & (US$ Million)
Table 66. Baxter International Recent Development
Table 67. Vartaris Company Detail
Table 68. Vartaris Business Overview
Table 69. Vartaris Motion Sickness Pills Product
Table 70. Vartaris Revenue in Motion Sickness Pills Business (2018-2023) & (US$ Million)
Table 71. Vartaris Recent Development
Table 72. Novartis Company Detail
Table 73. Novartis Business Overview
Table 74. Novartis Motion Sickness Pills Product
Table 75. Novartis Revenue in Motion Sickness Pills Business (2018-2023) & (US$ Million)
Table 76. Novartis Recent Development
Table 77. Pfizer Company Detail
Table 78. Pfizer Business Overview
Table 79. Pfizer Motion Sickness Pills Product
Table 80. Pfizer Revenue in Motion Sickness Pills Business (2018-2023) & (US$ Million)
Table 81. Pfizer Recent Development
Table 82. Myungmoon Pharm Company Detail
Table 83. Myungmoon Pharm Business Overview
Table 84. Myungmoon Pharm Motion Sickness Pills Product
Table 85. Myungmoon Pharm Revenue in Motion Sickness Pills Business (2018-2023) & (US$ Million)
Table 86. Myungmoon Pharm Recent Development
Table 87. Caleb Pharmaceuticals Company Detail
Table 88. Caleb Pharmaceuticals Business Overview
Table 89. Caleb Pharmaceuticals Motion Sickness Pills Product
Table 90. Caleb Pharmaceuticals Revenue in Motion Sickness Pills Business (2018-2023) & (US$ Million)
Table 91. Caleb Pharmaceuticals Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Motion Sickness Pills Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Motion Sickness Pills Market Share by Type: 2024 VS 2034
Figure 3. Anticholinergic Features
Figure 4. Antihistamines Features
Figure 5. Others Features
Figure 6. Global Motion Sickness Pills Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Motion Sickness Pills Market Share by Application: 2024 VS 2034
Figure 8. Adults Case Studies
Figure 9. Children Case Studies
Figure 10. Motion Sickness Pills Report Years Considered
Figure 11. Global Motion Sickness Pills Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 12. Global Motion Sickness Pills Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 13. Global Motion Sickness Pills Market Share by Region: 2024 VS 2034
Figure 14. Global Motion Sickness Pills Market Share by Players in 2024
Figure 15. Global Top Motion Sickness Pills Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Motion Sickness Pills as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Motion Sickness Pills Revenue in 2024
Figure 17. North America Motion Sickness Pills Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 18. North America Motion Sickness Pills Market Share by Country (2018-2034)
Figure 19. United States Motion Sickness Pills Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 20. Canada Motion Sickness Pills Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 21. Europe Motion Sickness Pills Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. Europe Motion Sickness Pills Market Share by Country (2018-2034)
Figure 23. Germany Motion Sickness Pills Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. France Motion Sickness Pills Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. U.K. Motion Sickness Pills Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. Italy Motion Sickness Pills Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. Russia Motion Sickness Pills Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Nordic Countries Motion Sickness Pills Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Asia-Pacific Motion Sickness Pills Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Asia-Pacific Motion Sickness Pills Market Share by Region (2018-2034)
Figure 31. China Motion Sickness Pills Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Japan Motion Sickness Pills Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. South Korea Motion Sickness Pills Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. Southeast Asia Motion Sickness Pills Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. India Motion Sickness Pills Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. Australia Motion Sickness Pills Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Latin America Motion Sickness Pills Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. Latin America Motion Sickness Pills Market Share by Country (2018-2034)
Figure 39. Mexico Motion Sickness Pills Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. Brazil Motion Sickness Pills Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Middle East & Africa Motion Sickness Pills Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Middle East & Africa Motion Sickness Pills Market Share by Country (2018-2034)
Figure 43. Turkey Motion Sickness Pills Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Saudi Arabia Motion Sickness Pills Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. GlaxoSmithKline Revenue Growth Rate in Motion Sickness Pills Business (2018-2023)
Figure 46. Prestige Brands Revenue Growth Rate in Motion Sickness Pills Business (2018-2023)
Figure 47. WellSpring Pharmaceutical Corporation Revenue Growth Rate in Motion Sickness Pills Business (2018-2023)
Figure 48. Baxter International Revenue Growth Rate in Motion Sickness Pills Business (2018-2023)
Figure 49. Vartaris Revenue Growth Rate in Motion Sickness Pills Business (2018-2023)
Figure 50. Novartis Revenue Growth Rate in Motion Sickness Pills Business (2018-2023)
Figure 51. Pfizer Revenue Growth Rate in Motion Sickness Pills Business (2018-2023)
Figure 52. Myungmoon Pharm Revenue Growth Rate in Motion Sickness Pills Business (2018-2023)
Figure 53. Caleb Pharmaceuticals Revenue Growth Rate in Motion Sickness Pills Business (2018-2023)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries